Larry Schlesinger, MD
Professor, President and CEO
Texas Biomedical Research Institute
Principal Investigator, Interdisciplinary NexGen TB Research Advancement Center (IN-TRAC)

Larry S. Schlesinger, MD became Professor, President and CEO of Texas Biomedical Research Institute in San Antonio, TX in 2017 and is leading a transformational process focused on scientific growth and cultural change, a new campus master plan and new research and education programs. He is a leading physician scientist whose research program focuses on how the lung environment shapes alveolar macrophage biology in the context of the pathogenesis of tuberculosis and diseases caused by other intracellular pathogens that subvert lung immune mechanisms. He translates these discoveries into new platforms and assays for host-directed therapies for infectious diseases. He has authored 260 peer-reviewed articles and reviews, served as editor of 2 books and has written several chapters in leading textbooks. He has been continually funded by the NIH and other federal agencies as well as private foundations such as the BMGF for more than 35 years. He has trained ~ 180 individuals and led NIH-funded training programs, including the Ohio State University MSTP 2011-2017. He is a past NIH NIAID Council member and Fellow of the AAAS, IDSA, AAP and AAM.